Sionna Therapeutics, Inc. Common Stock SION Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $18.96M+25.0% | $15.17M-5.5% | $16.04M+4.3% | $15.38M+12.5% | $13.67M-4.1% | ||
| $10.64M+26.0% | $8.44M+8.8% | $7.76M+19.0% | $6.52M+8.9% | $5.99M+54.4% | ||
| $29.6M+25.4% | $23.61M-0.8% | $23.81M+8.7% | $21.91M+11.4% | $19.66M+8.4% | ||
| -$29.6M-25.4% | -$23.61M+0.8% | -$23.81M-8.7% | -$21.91M-11.4% | -$19.66M-8.4% | ||
| $2.82M-11.1% | $3.17M-10.1% | $3.53M-8.1% | $3.84M+20.8% | $3.18M+39.0% | ||
| -$26.78M-31.0% | -$20.44M-0.8% | -$20.28M-12.2% | -$18.07M-9.6% | -$16.48M-4.0% | ||
| -$0.60-33.3% | -$0.45+2.2% | -$0.46+99.9% | -$410.00-66,029% | -$0.62+80.5% | ||
| -$29.45M-25.5% | -$23.46M+1.0% | -$23.71M-8.7% | -$21.81M-11.8% | -$19.5M-8.5% | ||
| -$29.6M-25.4% | -$23.61M+0.8% | -$23.81M-8.7% | -$21.91M-11.4% | -$19.66M-8.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Sionna Therapeutics, Inc. Common Stock's income statement data come from?
- Every line is extracted from Sionna Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.